insulin
INDIANAPOLIS, Ind. — Eli Lilly and Company said Wednesday that it is reducing the price of its most commonly prescribed insulins by as much as 70% and expanding a program that caps the monthly out-of-pocket cost for patients at $35.... Read More
WASHINGTON — A proposed $35 monthly cap on the price of insulin failed to win approval in the huge economic tax and spending package the Senate passed Sunday. Republicans succeeded in removing the cap by inserting an amendment into the... Read More
WASHINGTON (AP) — The House has passed a bill capping the monthly cost of insulin at $35 for insured patients, part of an election-year push by Democrats for price curbs on prescription drugs at a time of rising inflation. Experts... Read More
WASHINGTON — The House on Thursday is expected to vote to cap the out-of-pocket cost of insulin for consumers at $35 per month. If also passed by the Senate, which is expected to vote the measure up by Easter, the... Read More